BLOG

nature biotechnology

Can gene editing drive out HIV and hepatitis viruses from inside cells?

GigaGen, a subsidiary of Barcelona-based Grifols, aims to file an investigational new drug application next year, ahead of an initial trial of its recombinant polyclonal antibody therapy for chronic HBV infection